Ardoq Launches AI-First Enterprise Architecture Platform
28.5.2026 14:00:00 CEST | Business Wire | Press Release
Ardoq, named a 5x Leader in the Gartner® Magic Quadrant™ for Enterprise Architecture Tools, today launched its AI-first enterprise architecture (EA) platform. The release grounds every Ardoq AI output in customers' live architecture data and introduces a new generation of AI agents capable of automating an estimated 40% of routine EA work.
Architects today are being asked to defend decisions that generic AI is generating in seconds. Application rationalization choices. ERP transformation roadmaps. AI governance reviews. The questions land on the architect's desk, but the analysis underneath increasingly comes from AI assistants that do not know the architecture. Generic agents reason on whatever document is in front of them, not on the live relationships between applications, dependencies, capabilities, and risks. Ask a generic LLM to trace a five-step dependency chain across the real estate, and accuracy collapses. The answer arrives with confidence. The architect inherits the consequences.
Ardoq closes that gap. The AI capabilities released today reason on Ardoq's live architecture graph, the only place that holds every connection between every application, capability, and dependency in the customer's environment. Architects stay in the driver's seat. The AI does the heavy lifting on the analysis. The human keeps the judgment and the accountability. The graph keeps the reasoning chain visible. Every recommendation traces back to the underlying data, where the architect can interrogate, challenge, or override what the AI proposed. This is not a chatbot wrapped around enterprise data. It is structured reasoning on a graph the architect owns and governs, with permissions, lineage, and change control built into the foundation. That is the kind of system you cannot recreate with prompts.
New Capabilities Launching Today
Omnipresent AI Assistant (GA): A conversational interface available everywhere in the Ardoq platform, reasoning across the customer's entire data model in real time. Users ask architecture questions in plain language and receive instant, contextual answers traceable to source data.
AI Import Builder (GA): Connects any third-party data source to Ardoq in minutes with no technical setup required. Ardoq's AI agents read service documentation, configure the connection, and import data automatically.
Custom Agents (Open Beta): Customers can build and deploy their own AI agents, scoped to their architecture, metamodel, and workflows. Agents reason on live architecture data, not internet training data. Rolling out to partners in Q2 2026, customers thereafter.
Today's release is the latest milestone in the new Ardoq experience, the platform redesign that established the data foundation for Ardoq to build AI-first. The launch is accompanied by additional capabilities, including the Foundation Insights Agent, AI Query Builder, MCP SSO and AI Semantic Search, alongside technical previews of the Data Ingestion Agent, AI Web Search, and Agents for Out-of-the-Box Solutions.
Customer Success: Tenneco’s ROI
Tenneco, the global automotive technology company, is among the first customers achieving substantial returns from Ardoq AI. The company is building six AI agents in Microsoft Teams Copilot via the Ardoq MCP server, reclaiming 1.25 FTE within twelve months and targeting 40% of routine EA work automated by 2027.
"It feels like we're multiplying the team without multiplying headcount," said Abby Cletus, Head of Technology Strategy at Tenneco. "Ardoq AI is the only way we've found to get AI working on our actual architecture, not a stale export of it. The reasoning is traceable, the answers are auditable, and the team is spending its time on the decisions that matter."
A Repositioning Built on Substantiation
Ardoq shipped more than 100 features in 2025, doubling its prior innovation velocity year-over-year.
"The market has spent two years asking whether AI can be trusted with enterprise decisions," said Sunny Dhami, Chief Marketing Officer at Ardoq. "Today is our answer. Ardoq is the EA platform where AI reasons on a live architecture graph, outputs are traceable to source, and governance is built in by design, not bolted on. Generic AI invents architecture. Ardoq AI knows yours. And what we're announcing today is the foundation; there's significantly more coming through the rest of 2026."
Ardoq is a 2026 Gartner® Peer Insights™ Customers' Choice for Enterprise Architecture Tools, with the highest customer ratings of any EA vendor for willingness to recommend, customer support experience (4.9/5), and product capabilities (4.7/5), according to Gartner Peer Insights data as of March 31, 2026. The company has been named a Leader in five consecutive Gartner® Magic Quadrant™ reports for Enterprise Architecture Tools.
Today's announcement is the first in a planned series of releases from Ardoq through 2026. Additional Custom Agent capabilities, customer outcomes, partner integrations, and the next evolution of the graph data foundation are scheduled for the rest of the year.
About Ardoq
Ardoq is the AI-first Enterprise Architecture platform that turns enterprise complexity into connected intelligence. Built on a proprietary graph foundation, Ardoq helps organizations visualize how people, processes, and technologies interact, delivering real-time insight into how change impacts the business. Recognized as a 5x Leader in the Gartner® Magic Quadrant™ for Enterprise Architecture Tools and a 2026 Gartner® Peer Insights™ Customers' Choice. Founded in 2013 and headquartered in Oslo, Norway, Ardoq serves enterprises including ExxonMobil, MUFG, Stanley Black & Decker, Tenneco, Riot Games, Asda, STIHL, and Serta Simmons Bedding across financial services, energy, retail, technology, and government. Learn more at ardoq.com.
Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner's research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose. Gartner Peer Insights content consists of the opinions of individual end users based on their own experiences with the vendors listed on the platform, should not be construed as statements of fact, nor do they represent the views of Gartner or its affiliates. Gartner does not endorse any vendor, product or service depicted in this content nor makes any warranties, expressed or implied, with respect to this content, about its accuracy or completeness, including any warranties of merchantability or fitness for a particular purpose. GARTNER and Magic Quadrant are registered trademarks and service marks, and Peer Insights is a trademark and service mark, of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260528712753/en/
Contacts
Media contact:
Sunny Dhami,
Chief Marketing Officer, Ardoq
sunny.dhami@ardoq.com
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Wyss Geneva Steps Into Its Next Chapter11.6.2026 13:33:00 CEST | Press Release
The Wyss Center for Bio and Neuroengineering in Geneva is pleased to announce the appointment of Dr. Tracy Laabs as Director, effective July 1st 2026. Dr. Laabs succeeds Prof. Dr. Erwin Böttinger, who leaves behind a fundamentally transformed organization: one that no longer just pursues breakthrough science but systematically turns it into ventures that reach patients. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260611328520/en/ Dr. Tracy Laabs, incoming Director, Wyss Center Geneva Since joining the Wyss Center as Director in April 2023, Prof. Böttinger brought a bold vision: to evolve the Center from a portfolio of promising projects into a disciplined engine for venture creation. Under his leadership, the Center spun off six companies in two years (including ABILITY Neurotech SA and Clee Medical SA in 2025) while simultaneously building a robust pipeline of next-generation programs in AI-guided neuromodulation and min
BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit11.6.2026 13:24:00 CEST | Press Release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced the presentation of a large Phase 3 dataset in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) aged 80 and older, showing sustained benefit with BRUKINSA after nearly 6.5 years of follow-up, reinforcing its role as the foundational BTK inhibitor. BRUKINSA is the only BTK inhibitor to demonstrate superior efficacy vs. ibrutinib in a Phase 3 trial.1 These data, one of the largest datasets of older patients with treatment-naive CLL, will be presented at the 2026 European Hematology Association (EHA) Congress in Stockholm, Sweden. Amit Agarwal, M.D., Ph.D., Chief Medical Officer, Hematology, BeOne Medicines, said: "While the median age of diagnosis for CLL is 70 and the average age of treatment initiation is 75, many pivotal trials still underrepresent the patients that physicians most often see in practice. These data show that the durable benefit of
Takeda’s Zasocitinib Significantly Outperforms Deucravacitinib in Head-to-Head Phase 3 Psoriasis Study, Promising to Redefine Oral Treatment Expectations11.6.2026 13:00:00 CEST | Press Release
Takeda (TSE:4502/NYSE:TAK) announced positive topline results for the Phase 3, randomized, multicenter, double-blind study comparing zasocitinib (TAK-279), an investigational, next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, to deucravacitinib in adults with moderate-to-severe plaque psoriasis (PsO). In the LATITUDE Atlas (TAK-279-PsO-3004) head-to-head study, zasocitinib demonstrated statistical superiority over deucravacitinib for the primary endpoint, Psoriasis Area and Severity Index (PASI) 100 response rate at week 16. The study also demonstrated statistical superiority over deucravacitinib for all key secondary endpoints, including PASI 90 response and Static Physician's Global Assessment (sPGA) 0 at week 16. Zasocitinib was generally well tolerated with a consistent safety and tolerability profile and no new safety signals identified. Perspectives on head-to-head zasocitinib study “In this head-to-head study, zasocitinib clearly demonstrated
Clearlake Expands Liquid Credit Platform With Acquisition of LCM Asset Management’s CLO Contracts11.6.2026 13:00:00 CEST | Press Release
Clearlake Capital Group, L.P. (“Clearlake” or the “Firm”), a global investment firm managing integrated platforms spanning private equity, liquid and private credit, and other related strategies, today announced that its credit platform, Clearlake Credit, will assume management of CLOs managed by LCM Asset Management, LLC. The transaction adds 31 CLOs representing more than $5 billion of assets under management and increases assets managed by Clearlake Credit to approximately $39 billion across liquid credit, private credit, and other customized credit solutions. The acquisition further broadens the Firm’s capabilities, deepens its relationships with institutional investors, and reinforces its client-centric approach and commitment to seeking attractive risk-adjusted returns across market cycles. Milbank LLP and Dechert LLP represented Clearlake Credit in the transaction. GreensLedge Capital Markets advised the seller. About Clearlake Clearlake Capital is a leading global alternative a
L&T Technology Services, Databricks Partner to Deliver Industrial AI at Scale for Asset-Intensive Industries11.6.2026 12:30:00 CEST | Press Release
L&T Technology Services (BSE: 540115, NSE: LTTS), a global leader in AI, Digital & ER&D Consulting Services, today announced a strategic go-to-market partnership with Databricks, the leading Data and AI company, to co-develop and deliver Industrial AI solutions that advance Engineering Intelligence (EI) for asset-intensive enterprises. Anchored in LTTS' Sustainability segment, spanning Process Engineering, Discrete Manufacturing and Industrial Products, the partnership will support Energy, Petrochemicals and Industrials clients globally. As industrial organizations seek to unlock greater value from decades of operational and engineering data, the alliance will combine LTTS’ deep domain capabilities with the Databricks platform to transform complex plant data into Engineering Intelligence - enabling improved asset reliability, operational efficiency and sustainability performance. The partnership brings together LTTS’ expertise in forward looking technologies and extensive experience ac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom